Lupus Suppressant Hydroxychloroquine To Expand At A CAGR Of 4.5% During The Forecast Period 2022-2032
In the wake of the worsening coronavirus pandemic, hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a …